Pavel Babica Selected Research

1-methylanthracene

1/2014

Polycyclic aromatic hydrocarbon-induced signaling events relevant to inflammation and tumorigenesis in lung cells are dependent on molecular structure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pavel Babica Research Topics

Disease

10	Neoplasms (Cancer) 08/2021 - 04/2008
2	Fatty Liver 05/2024 - 01/2019
2	Carcinogenesis 01/2016 - 01/2014
1	Shellfish Poisoning 01/2024
1	Wounds and Injuries (Trauma) 03/2023
1	Metabolic Diseases (Metabolic Disease) 12/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Obesity 01/2022
1	Bacterial Infections (Bacterial Infection) 03/2021
1	Lung Diseases (Lung Disease) 10/2020
1	Hepatocellular Carcinoma (Hepatoma) 10/2020
1	Inflammation (Inflammations) 01/2014
1	Adenocarcinoma of Lung 01/2014
1	Hepatomegaly 04/2009

Drug/Important Bio-Agent (IBA)

3	CarcinogensIBA 08/2021 - 04/2009
3	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 10/2020 - 04/2008
3	Biomarkers (Surrogate Marker)IBA 09/2012 - 01/2010
2	Mitogen-Activated Protein KinasesIBA 07/2011 - 01/2010
1	cylindrospermopsinIBA 05/2024
1	NeurotoxinsIBA 01/2024
1	AerosolsIBA 03/2023
1	Endocrine DisruptorsIBA 12/2022
1	AntioxidantsIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	PolymersIBA 03/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2021
1	Cytotoxins (Cytolysins)IBA 10/2020
1	Fluorouracil (Carac)FDA LinkGeneric 10/2020
1	LipidsIBA 01/2019
1	AlbuminsIBA 01/2019
1	cyanoginosin LR (microcystin LR)IBA 01/2018
1	PhytochemicalsIBA 01/2015
1	1-methylanthraceneIBA 01/2014
1	2-methylanthraceneIBA 01/2014
1	MicrocystinsIBA 01/2010
1	Cyanobacteria ToxinsIBA 01/2010
1	perfluorooctanoic acidIBA 04/2009
1	Peroxisome ProliferatorsIBA 04/2009
1	phosphatidylcholine-specific phospholipase CIBA 04/2008
1	SmokeIBA 04/2008

Therapy/Procedure

1	Therapeutics 01/2022